Health economics of endometriosis
article
OA: closed
CC0
⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the health economics of endometriosis, covering its prevalence, direct and indirect costs, and the economic impact of diagnostic delays and treatment options.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review 2020
- Simple Immunocytochemistry from Menstrual Blood in Diagnosis of Endometriosis 2019
- Update on Biomarkers for the Detection of Endometriosis 2015
- Biomarkers of endometriosis 2013
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres 2012
- Endometriosis Cost Assessment (the EndoCost Study): A Cost-of-Illness Study Protocol 2010
- Future of Endometriosis Research 2007
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK